Mahaweni, N. M., Bos, G. M. J., Mitsiades, C. S., Tilanus, M. G. J., & Wieten, L. (2018). Daratumumab augments alloreactive natural killer cell cytotoxicity towards CD38+ multiple myeloma cell lines in a biochemical context mimicking tumour microenvironment conditions. Cancer Immunol Immunother.
Citação norma ChicagoMahaweni, Niken M., Gerard M. J. Bos, Constantine S. Mitsiades, Marcel G. J. Tilanus, and Lotte Wieten. "Daratumumab Augments Alloreactive Natural Killer Cell Cytotoxicity Towards CD38+ Multiple Myeloma Cell Lines in a Biochemical Context Mimicking Tumour Microenvironment Conditions." Cancer Immunol Immunother 2018.
Citação norma MLAMahaweni, Niken M., et al. "Daratumumab Augments Alloreactive Natural Killer Cell Cytotoxicity Towards CD38+ Multiple Myeloma Cell Lines in a Biochemical Context Mimicking Tumour Microenvironment Conditions." Cancer Immunol Immunother 2018.